117997-81-6

Basic information

• Product Name: Boc-DL-Glu(OBzl)-OH
• Synonyms: Boc-DL-glutamic acid γ-benzyl ester≥ 99% (TLC)
• CAS NO: 117997-81-6
• Molecular Formula: C₁₇H₂₃NO₆
• Molecular Weight: 337.37
• Mol File: 117997-81-6.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 522.6±50.0 °C(Predicted)
• Appearance: /
• Density: 1 +-.0.06 g/cm3(Predicted)
• Storage Temp.: Store at RT.
• PKA: 3.81±0.10(Predicted)
• CAS DataBase Reference: Boc-DL-Glu(OBzl)-OH(CAS DataBase Reference)
• NIST Chemistry Reference: Boc-DL-Glu(OBzl)-OH(117997-81-6)
• EPA Substance Registry System: Boc-DL-Glu(OBzl)-OH(117997-81-6)

Safety Data

• Hazardous Substances Data: 117997-81-6(Hazardous Substances Data)

Usage

Chemical Properties

White powder

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 29456-09-5 L-glutamic acid γ-benzyl ester 

Downstream Products

• 105751-09-5 2-[2-(4-Benzyloxycarbonyl-2-tert-butoxycarbonylamino-butyrylamino)-3-(diphenoxy-phosphoryloxy)-propionylamino]-4-methyl-pentanoic acid benzyl ester 
• 95656-84-1 benzyl 4-((tert-butoxycarbonyl)amino)butanoate 
• 118100-26-8 N^α-Boc-ε-benzyl-DL-glutamic acid dipentylamide 
• 7536-59-6 4-nitrophenyl γ-benzyl-N-tert-butoxycarbonylglutamate 
• 122262-04-8 N,N'-bis(tert-butoxycarbonyl-γ-benzylglutamylphenylalanyl)ethylenediamine 
• 105751-11-9 2-[2-(2-Amino-4-carboxy-butyrylamino)-3-(diphenoxy-phosphoryloxy)-propionylamino]-4-methyl-pentanoic acid; compound with trifluoro-acetic acid 
• 117997-60-1 (RS)-4-[(4-chlorophenylaminocarbonyl)amino]-5-(dipentylamino)-5-oxo-pentanoic acid 
• 123540-70-5 4-[3-(4-Chloro-phenyl)-ureido]-4-dipentylcarbamoyl-butyric acid ethyl ester 
• 123540-71-6 2-[3-(4-Chloro-phenyl)-ureido]-5-oxo-5-pyrrolidin-1-yl-pentanoic acid dipentylamide 
• 117997-61-2 4-[3-(4-Chloro-phenyl)-ureido]-4-dipentylcarbamoyl-butyric acid benzyl ester 
• 118100-27-9 ε-benzyl-DL-glutamic acid dipentylamide hydrochloride 

Relevant articles and documents

Glutathione modified low molecular weight PEI for highly improved gene transfection ability and biocompatibility

The efficient delivery of therapeutic genes remains a major challenge in realizing a feasible gene-based treatment. Herein, a versatile oligopeptide, glutathione, was introduced to construct novel non-viral cationic gene vectors. Reduced/oxidized forms of

Benzyl and p-nitrobenzyl monoesters of N-t-butyloxycarbonyl-L-glutamic acid and N-t-butyloxycarbonyl-L-aspartic acid.

-